Tech Company Financing Transactions
NextWave Pharmaceuticals Funding Round
NextWave Pharmaceuticals, operating out of Cupertino, secured $6.9 million in funding from F-Prime Capital and Sofinnova Ventures.
Transaction Overview
Company Name
Announced On
6/30/2009
Transaction Type
Venture Equity
Amount
$6,917,000
Round
Undisclosed
Investors
F-Prime Capital (Stephen Knight)
Sofinnova Ventures (James Healy)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
20450 Stevens Creek Boulevard 150
Cupertino, CA 95014
USA
Cupertino, CA 95014
USA
Phone
Website
Email Address
Overview
By listening to the needs of parents and children, and working closely with the pediatric community, including pediatricians, physician assistants and nurse practitioners, NextWave Pharmaceuticals is developing a broad line of products across several therapeutic areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Shepard
Chief Financial Officer
Cynthia Butitta
VP - Bus. Development
Craig Chambliss
VP - Product Management
Michael Burdick
VP - Sales
Alan Birtchet
VP - Sales
Tracy Woody
Browse more venture capital transactions:
Prev: 6/30/2009: Visioneering Technologies venture capital transaction
Next: 6/30/2009: Tesla venture capital transaction
Share this article
News on VC Transactions
We report on tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs